The cardiovascular drug market has seen big developments in recent years, as warfarin and old-line statins have given way to next-generation blood thinners and novel, high-priced cholesterol fighters.

7 January 2026 As he hands over the baton, Bobby Mukherjee reflects on his time leading the Chartered Institute of Patent ...

Xarelto and Eliquis are two of 10 drugs whose Medicare prices have been negotiated down, threatening long-term care pharmacies’ financial viability. (Photo: Scott Olson/Staff/Getty Images) Facing deep ...

Please provide your email address to receive an email when new articles are posted on . Seven cardiometabolic medications incur the most Medicare Part D spending among drugs up for price negotiation.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...

The brand-name drugs covered under Medicare Part D have nearly doubled in price, and 25 of them are now up 98% since they debuted in the market, a new AARP Public Policy Institute analysis has found.

Sandoz is introducing generic rivaroxaban in Germany, in new generic strengths of 10 mg, 15 mg and 20 mg. Rivaroxaban - 1 A Pharma is a generic of Bayer Intellectual Property GmbH’s Xarelto. Sandoz ...